BioSpring Competitors and Similar CompaniesClear all
BioSpring's competitors and similar companies include Cogent Biosciences, Athos Therapeutics, Orchard Therapeutics and Stealth BioTherapeutics.
 BioSpring BioSpring Gesellschaft für Biotechnologie is a company that specializes in nucleic acid manufacturing technology. |  Cogent Biosciences Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases. |  Athos Therapeutics Athos Therapeutics is a clinical-stage biotechnology company that develops AI-based precision therapeutics. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. | |
Founding Date | Founding Date 1997 | Founding Date 2014 | Founding Date 2019 | Founding Date 2015 | Founding Date 2007 |
Type | Type Subsidiary | Type Public | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Frankfurt am Main, DE HQ Chiyoda, JP San Diego, US | Locations Waltham, US HQ Boulder, US | Locations Torrance, US HQ | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US |
Employees | Employees 3641% decrease | Employees 25826% increase | Employees 316% decrease | Employees 166 | Employees 592% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 18.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) €61.4m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods €20.1m (FY, 2020) | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.8m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit €41.3m (FY, 2020) | Gross profit N/A | Gross profit N/A | Gross profit $15.9m (FY, 2022) | Gross profit N/A |
Net income | Net income €11.2m (FY, 2020) | Net income ($328.9m) (FY, 2025) | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 178.3m | Total funding raised N/A | Total funding raised $ 310.7m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Cogent Biosciences
HQ
Waltham, US
Employees
258↑ 26% increase
Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases.
View companyAthos Therapeutics
HQ
Torrance, US
Employees
31↓ 6% decrease
Athos Therapeutics is a clinical-stage biotechnology company that develops AI-based precision therapeutics.
View companyOrchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View company